Tyler F. Jacks Ph.D.
|Age||Total Calculated Compensation||This person is connected to 80 board members in 5 different organizations across 7 different industries.|
See Board Relationships
Dr. Tyler F. Jacks, Ph.D., serves as Director of the Center for Cancer Research of the Massachusetts Institute of Technology. Dr. Jacks serves as Professor of Biology at MIT. He co-founded T2 Biosystems, Inc., in 2006. He joined at MIT in 1992 as a faculty. He served as Member of Scientific Advisory Board at Aveo Pharmaceuticals, Inc. He served as the Chairman of the Scientific Advisory Board of NexGenix Pharmaceuticals Holdings, Inc. He serves as Co-Chairman of Research ...
615 Chestnut StreetPhone: 215-440-9300
Philadelphia, Pennsylvania 19106-4404
Board Members Memberships*
Director and Member of Scientific Advisory Board
University of California
University of California-San Francisco
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Paolo Pucci||Chief Executive Officer and Director|
|Michael M. Morrissey Ph.D.||Chief Executive Officer, President and Director|
|Pascal Soriot||Chief Executive Officer, Executive Director and Member of Disclosure Committee|
|Christophe Weber||Chief Executive Officer, President and Representative Director|
Takeda Pharmaceutical Company Limited
|¥495.0M||Compensation as of Fiscal Year 2015.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.